Symbol="HRTX"
AssetType="Common Stock"
Name="Heron Therapeuti"
Description="Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. The company is headquartered in San Diego, California."
CIK="818033"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="194439000"
EBITDA="-136512000"
PERatio="None"
PEGRatio="-0.18"
BookValue="-0.096"
DividendPerShare="0"
DividendYield="0"
EPS="-1.28"
RevenuePerShareTTM="1.006"
ProfitMargin="-1.326"
OperatingMarginTTM="-1.225"
ReturnOnAssetsTTM="-0.352"
ReturnOnEquityTTM="-24.09"
RevenueTTM="113830000"
GrossProfitTTM="-50508000"
DilutedEPSTTM="-1.28"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.263"
AnalystTargetPrice="7.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.072"
PriceToBookRatio="13.82"
EVToRevenue="3.526"
EVToEBITDA="-1.687"
Beta="0.994"
num_52WeekHigh="5.62"
num_52WeekLow="1.07"
num_50DayMovingAverage="1.302"
num_200DayMovingAverage="2.302"
SharesOutstanding="120024000"
DividendDate="None"
ExDividendDate="None"
symbol="HRTX"
open="1.64"
high="1.71"
low="1.62"
price="1.66"
volume="1415360.00"
latest_trading_day="2023-08-04"
previous_close="1.62"
change="0.04"
change_percent="2.4691%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="96"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="4"
Volume_recent_avg="2336883"
Change_recent_avg="-0.01"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-1.0"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="4"
Aroon_momentum_negative="96"
image_negative_thumbnail_id_1="1154"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0188.jpeg"
image_negative_thumbnail_id_2="137"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0039.jpeg"
image_neutral_thumbnail_id_1="528"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="985"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0147.jpeg"
image_positive_thumbnail_id_2="1166"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
